HIV is a medical issue that has been confounding scientists for years, eluding effective forms of countermeasures throughout the decades. With the advent of the gene-editing tool CRISPR, however, researchers may have finally gotten the tool they needed to put an end to the deadly pathogen. In a recent case, for example, scientists were able to raise the resistance of animals to HIV with the help of CRISPR.
One of the biggest reasons for why HIV is so hard to cure is its ability to hide, Futurism notes, which makes it difficult to create drugs that would target the viruses. Scientists have been trying for decades without much success. That’s why some Chinese researchers decided to take another approach to combating HIV. Instead of developing a drug, they simply opted to improve resistance to the virus.
Led by Hu Chen, the researchers conducted a study that looked into inducing mutations in mice via CRISPR. The goal is to make the rodents more resistant to HIV by manipulating the CCR5 gene.
The idea came from previous data collected that indicated how mutations in the gene could provide subjects with the ability to prevent getting infected by HIV. Unfortunately, only a select number of people had this mutation. By trying to see if the mutation can be controlled to apply to only that specific aspect of the gene, success could lead to complete immunity from the virus.
Based on the paper that the researchers published, the results of their work seems promising. This is largely due to the advent of CRISPR. As the researchers said in an interview with The Scientist, the gene-editing tool simply makes it too easy to manipulate cells.
It’s worth pointing out that this study only applies to increased resistance to HIV in animals and more tests are necessary to see the effects on humans. Even so, it’s an encouraging peek into the possibilities where CRISPR is concerned.


FDA Pilot Program Eases Rules for Nicotine Pouch Makers
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 



